Document Detail


Predictors of an increased risk of future hypertension in Utah. A screening analysis.
MedLine Citation:
PMID:  2045178     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A prospective study on 1,482 adult members of 98 Utah pedigrees was carried out to determine which variables may be associated with an increased risk of hypertension incidence. After an average of 7 years of follow-up, 40 individuals had been placed on antihypertensive medications to lower blood pressure. Baseline study variables included anthropometrics, clinical chemistry measurements of blood and urine, socioeconomic and lifestyle variables, and detailed erythrocyte ion transport and concentration measurements. Age (relative risk of 4.28 for a 2 SD difference, p less than 0.0001) and baseline systolic and diastolic blood pressures (relative risks of 3.55 and 3.52, respectively, both p less than 0.0001) had the strongest associations with hypertension incidence. Controlling for age and baseline blood pressure, the following age- and sex-adjusted variables were associated with an increased risk of future hypertension (relative risks for a 2 SD difference, all p less than 0.10): family history of hypertension (2.35); height (1.97); body mass index (2.31); abdominal girth (2.66); subscapular, suprailiac, and triceps skinfold thicknesses (2.79, 2.52, and 2.28, respectively); percent ideal body weight (2.63); log triglyceride concentration (2.02); plasma uric acid (2.16); inorganic phosphate (0.50); and passive erythrocyte sodium permeability (1.59). The final model,which included all of the age- and sex-adjusted variables (p less than 0.10) in a backward elimination logistic regression analysis, consisted of age (4.78), systolic blood pressure (2.91), subscapular skinfold thickness (2.21), height (1.92), uric acid (2.06), inorganic phosphate (0.50), and family history of hypertension (1.82). None of the ion transport or concentration measurements ws associated with an increased risk of hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
S C Hunt; S H Stephenson; P N Hopkins; R R Williams
Related Documents :
19863868 - The current state of raas blockade in the treatment of hypertension and proteinuria.
22323128 - Upper esophageal sphincter impedance as a marker of sphincter opening diameter.
9234838 - Detection of preclinical atherosclerosis may optimize the management of hypertension.
22367508 - Effect of heat stress on cardiac output and systemic vascular conductance during simula...
17572748 - Pressure measurement in supersonic air flow by differential absorptive laser-induced th...
21883958 - Effects of hyperoxic ventilation on 6-hours survival at the critical haemoglobin concen...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Hypertension     Volume:  17     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  1991 Jun 
Date Detail:
Created Date:  1991-07-12     Completed Date:  1991-07-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  969-76     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure
Body Mass Index
Female
Forecasting
Humans
Hypertension / etiology*,  genetics
Male
Middle Aged
Phosphates / blood
Prospective Studies
Regression Analysis
Risk Factors
Triglycerides / blood
Uric Acid / blood
Grant Support
ID/Acronym/Agency:
HL-21088/HL/NHLBI NIH HHS; HL-24855/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Phosphates; 0/Triglycerides; 69-93-2/Uric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of sympathetic activity in blood pressure reduction with low calorie regimen.
Next Document:  Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan.